Grade 1 endometrial endometrioid carcinoma
Clinical trials for Grade 1 endometrial endometrioid carcinoma explained in plain language.
Never miss a new study
Get alerted when new Grade 1 endometrial endometrioid carcinoma trials appear
Sign up with your email to follow new studies for Grade 1 endometrial endometrioid carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Weight-Loss drug meets hormonal IUD in hunt for Surgery-Free cancer care
Disease control Not yet recruitingResearchers are testing whether adding tirzepatide, a weekly drug that treats obesity and diabetes, to a standard levonorgestrel-releasing intrauterine device can help clear early endometrial cancer or a precancerous condition called endometrial intraepithelial neoplasia. The stu…
Matched conditions: GRADE 1 ENDOMETRIAL ENDOMETRIOID CARCINOMA
Early phase 1 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Weight-Loss drug may slow uterine tumors before surgery
Disease control Not yet recruitingThis study tests whether tirzepatide, a drug used for diabetes and weight loss, can slow or stop the growth of early-stage endometrial cancer or its precursor (EIN) in women with obesity. Forty participants will receive either tirzepatide or no additional treatment for 4 weeks be…
Matched conditions: GRADE 1 ENDOMETRIAL ENDOMETRIOID CARCINOMA
Phase 2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC